SCHEMBL5451947

SCHEMBL5451947

O=C(O)c1ccccc1C(=O)C1CCCC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.56
ALOX15 P16050 1/20 0.56
CPB1 P15086 1/20 0.53
SRD5A2 P31213 1/20 0.49
HPGD P15428 3/20 0.46
AKR1C3 P42330 1/20 0.45
GAA P10253 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
KDM4E B2RXH2 2/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
HMGB1 P09429 1/20 0.43
CA4 P22748 1/20 0.43
CA6 P23280 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
NAPRT Q6XQN6 1/20 0.43
CA14 Q9ULX7 1/20 0.43
LMNA P02545 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3027381 0.98 ALDH1A1 (0.54) ALDH1A1ALOX15CPB1SRD5A2HPGD
SCHEMBL5462752 0.96 ALDH1A1 (0.56) ALDH1A1ALOX15CPB1SRD5A2HPGD
Phthalic Acid SCHEMBL27732928 0.84 ALDH1A1 (0.56) ALDH1A1ALOX15CPB1SRD5A2HPGD
SCHEMBL8536616 0.83 ALDH1A1 (0.50) ALDH1A1ALOX15CPB1HPGDAKR1C3
SCHEMBL8536613 0.83 ALDH1A1 (0.50) ALDH1A1ALOX15CPB1HPGDAKR1C3
SCHEMBL29004698 0.81 ALDH1A1 (0.52) ALDH1A1ALOX15CPB1HPGDAKR1C3
Phthalic Acid SCHEMBL30731306 0.81 ALDH1A1 (0.52) ALDH1A1ALOX15CPB1HPGDAKR1C3
Phthalic Acid SCHEMBL27812813 0.81 ALDH1A1 (0.52) ALDH1A1ALOX15CPB1HPGDAKR1C3
SCHEMBL3389632 0.80 KDM2B (0.57) ALDH1A1HPGDGAARAB9AMAPT
SCHEMBL10405163 0.79 ALDH1A1 (0.45) ALDH1A1SRD5A2HPGDGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004018414-A2 ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO claimed
US-20070191420-A1 Kinase inhibitors DEVGEN NV 2007-08-16 US disclosed
EP-1715862-A1 KINASE INHIBITORS Devgen NV (BE) 2006-11-02 EP disclosed
WO-2005082367-A1 KINASE INHIBITORS DEVGEN NV (BE) 2005-09-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191420-A1 Kinase inhibitors ROCK1, ROCK2, MAP3K20 ALDH1A1 4377/4885ALOX15 3562/4885CPB1 3529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.